This study identified six transcripts (GS1-304P7.3, NONHSAT090268, TC0100011037, TC0400008478, TC1400008125, and UBE2V1) showing an altered expression in the plasma of mild-moderate AD patients compared to unaffected individuals. This evidence concerns the gene UBE2V1 and Alzheimer disease.